Scholar Rock Holding (SRRK) Non-Current Assets (2017 - 2026)

Scholar Rock Holding's (SRRK) quarterly Non-Current Assets came in at $20.0 million in Q1 2026, down 10.47% year-on-year from $22.3 million in Q1 2025, and up 4.42% quarter-over-quarter from $19.1 million in Q4 2025.

Scholar Rock Holding (SRRK) Non-Current Assets (2017 - 2026) Analysis & Trends

Scholar Rock Holding's Non-Current Assets history runs 10 years deep, the most recent figure standing at $20.0 million for Q1 2026.

  • On a quarterly basis, Non-Current Assets fell 10.47% year-over-year to $20.0 million in Q1 2026; TTM through Mar 2026 was $81.0 million, a 18.98% decrease from a year earlier, with the FY2025 full-year figure at $19.1 million, down 19.5% from the prior year.
  • Non-Current Assets climbed to $20.0 million in Q1 2026 per SRRK's latest filing, from $19.1 million in the prior quarter.
  • Across five years, Non-Current Assets topped out at $37.4 million in Q1 2022 and bottomed at $19.1 million in Q4 2025.
  • The 5-year median for Non-Current Assets is $23.8 million (2024), against an average of $25.5 million.
  • Across the five-year window, Non-Current Assets slumped 32.02% in 2023 and increased 17.92% in 2024, its largest moves.
  • Year by year, Non-Current Assets stood at $30.1 million in 2022, then declined by 24.23% to $22.8 million in 2023, then rose by 4.01% to $23.8 million in 2024, then slipped by 19.5% to $19.1 million in 2025, then gained by 4.42% to $20.0 million in 2026.
  • Per Business Quant, the three latest SRRK Non-Current Assets figures stand at $20.0 million (Q1 2026), $19.1 million (Q4 2025), and $21.0 million (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Assets (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - 21.65 Mn
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - 5.83 Mn
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 1.95 Bn
4 NuCana 279.75 Bn 279.75 Bn - 3.95 Mn
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 14.75 Bn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 22.66 Bn
7 Belite Bio 62.51 Bn 62.51 Bn - 289.41 Mn
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn 1.96 Bn
9 Revolution Medicines 37.78 Bn 37.78 Bn - 285.82 Mn
10 Scholar Rock Holding 6.30 Bn 6.30 Bn - 19.97 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 19.97 Mn
Dec 31, 2025 19.13 Mn
Sep 30, 2025 21.01 Mn
Jun 30, 2025 20.92 Mn
Mar 31, 2025 22.31 Mn
Dec 31, 2024 23.76 Mn
Sep 30, 2024 26.21 Mn
Jun 30, 2024 27.73 Mn
Mar 31, 2024 20.35 Mn
Dec 31, 2023 22.84 Mn
Sep 30, 2023 22.22 Mn
Jun 30, 2023 25.09 Mn
Mar 31, 2023 27.56 Mn
Dec 31, 2022 30.14 Mn
Sep 30, 2022 32.69 Mn
Jun 30, 2022 34.99 Mn
Mar 31, 2022 37.39 Mn
Dec 31, 2021 39.13 Mn
Sep 30, 2021 40.23 Mn
Jun 30, 2021 41.69 Mn